Assisted Reproductive Technology Surveillance — United States, 2016
MMWR. Surveillance Summaries · 26.04.2019 · 68 (4) · 1-23
DOI: 10.15585/mmwr.ss6804a1 ↗Kurz gefasst
Fachartikel in der Zeitschrift MMWR. Surveillance Summaries, online erschienen am 26.04.2019. Verfasst von Saswati Sunderam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC. Hauptthemen laut MEDLINE: Population Surveillance, Pregnancy Outcome. Die Arbeit wurde bisher 148-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PROBLEM/CONDITION: Since the first U.S. infant conceived with assisted reproductive technology (ART) was born in 1981, both the use of ART and the number of fertility clinics providing ART services have increased steadily in the United States. ART includes fertility treatments in which eggs or embryos are handled in the laboratory (i.e., in vitro fertilization [IVF] and related procedures). Although the majority of infants conceived through ART are singletons, women who undergo ART procedures are more likely than women who conceive naturally to deliver multiple-birth infants. Multiple births pose substantial risks for both mothers and infants, including obstetric complications, preterm delivery ( 37 years). Among women aged 1.5 times the national average. Although other factors might influence ART use, insurance coverage for infertility treatments accounts for some of the difference in per capita ART use observed among states because most states do not mandate any coverage for ART treatment. PUBLIC HEALTH ACTION: Twins account for almost all of ART-conceived multiple births born in multiple deliveries. Reducing the number of embryos transferred and increasing use of eSET, when clinically appropriate, could help reduce multiple births and related adverse health consequences for both mothers and infants. Because multiple-birth infants are at increased risk for numerous adverse sequelae that cannot be ascertained from the data collected through NASS alone, long-term follow-up of ART infants through integration of existing maternal and infant health surveillance systems and registries with data available from NASS might be useful for monitoring adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.
- Emory University School of Medicine, Atlanta, Georgia.
Zitieren
APA
Sunderam, S., Kissin, D. M., Zhang, Y., Folger, S. G., Boulet, S. L., Warner, L., Callaghan, W. M., & Barfield, W. D. (2019). Assisted Reproductive Technology Surveillance — United States, 2016. MMWR. Surveillance Summaries, 68(4), 1-23. https://doi.org/10.15585/mmwr.ss6804a1
Vancouver
Sunderam S, Kissin DM, Zhang Y, Folger SG, Boulet SL, Warner L, et al. Assisted Reproductive Technology Surveillance — United States, 2016. MMWR. Surveillance Summaries. 2019;68(4):1-23. doi:10.15585/mmwr.ss6804a1
BibTeX
@article{Sunderam2019,
author = {Sunderam, Saswati and Kissin, Dmitry M and Zhang, Yujia and Folger, Suzanne G and Boulet, Sheree L and Warner, Lee and Callaghan, William M and Barfield, Wanda D},
title = {Assisted Reproductive Technology Surveillance — United States, 2016},
journal = {MMWR. Surveillance Summaries},
year = {2019},
volume = {68},
number = {4},
pages = {1--23},
doi = {10.15585/mmwr.ss6804a1}
}
EUVIMED